Article
Fitness and infectivity of drug-resistant and cross-resistant hepatitis B virus mutants: why and how is it studied?
Antiviral therapy - 1 Jan 2010
Durantel David
Abstract excerpt
The emergence of hepatitis B virus (HBV) drug-resistant (and multidrug-resistant) strains during long-term therapy with nucleoside/nucleotide analogues is associated with treatment failure and, therefore, represents a clinical challenge. For clinicians, the close monitoring and management of resi...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
